Related content

Preemptive use of interferon or lamivudine for hepatitis B reactivation in patients with aggressive lymphoma receiving chemotherapy

By Leaw Shiang   Yen Chia   Huang Wen   Chen Tsai   Su Wu   Tsao Chao  

Annals of Hematology, Vol. 83, Iss. 5, 2004-05 ,pp. : 270-275

Springer Publishing Company

Access to resources Recommend Favorite

Possible efficacy of lamivudine treatment to prevent hepatitis B virus reactivation due to rituximab therapy in a patient with non-Hodgkin's lymphoma

By Tsutsumi Y.  

Annals of Hematology, Vol. 83, Iss. 1, 2004-01 ,pp. : 58-60

Springer Publishing Company

Access to resources Recommend Favorite

Reactivation of hepatitis B virus during rituximab treatment of a patient with follicular lymphoma

By Yang Shih-Hung  

Annals of Hematology, Vol. 87, Iss. 4, 2008-04 ,pp. : 325-327

Springer Publishing Company

Access to resources Recommend Favorite

The effectiveness of lamivudine in preventing hepatitis B viral reactivation in rituximab-containing regimen for lymphoma

By He Yi-Fu  

Annals of Hematology, Vol. 87, Iss. 6, 2008-06 ,pp. : 481-485

Springer Publishing Company

Access to resources Recommend Favorite

Higher fungal infection rate in elderly patients (more than 80 years old) suffering from diffuse large B cell lymphoma and treated with rituximab plus CHOP

By Lin Peng-Chan   Hsiao Liang-Tsai   Poh Say-Bee   Wang Wei-Shu   Yen Chueh-Chuan   Chao Ta-Chung   Liu Jin-Hwang   Chiou Tzeon-Jye   Chen Po-Min  

Annals of Hematology, Vol. 86, Iss. 2, 2007-02 ,pp. : 95-100

Springer Publishing Company

Access to resources Recommend Favorite